Cholinergic Anti-Inflammatory Pathway and the Liver

Hajiasgharzadeh, Khalil and Baradaran, Behzad (2017) Cholinergic Anti-Inflammatory Pathway and the Liver. Advanced Pharmaceutical Bulletin, 7 (4). pp. 507-513. ISSN 2228-5881

[thumbnail of apb-7-507.pdf] Text
apb-7-507.pdf - Published Version

Download (563kB)

Abstract

The hepatic vagus branches innervate the liver and serve an important role in liver-brain connection. It appears that brain modulates inflammatory responses by activation of vagal efferent fibers. This activation and subsequent acetylcholine releases from vagus nerve terminals leads to inhibition of inflammatory cytokines through α7 nicotinic acetylcholine receptors (α7nAChRs) which located on the surface of different cell types such as liver Kupffer cells. This protective role of vagus-α7nAChR axis in liver diseases has been shown in several experimental studies. On the other hand, accumulated evidence clearly demonstrate that, autonomic dysfunction which is reduced functioning of both vagal and sympathetic nervous system, occurs during chronic liver disease and is well-known complication of patients suffering from cirrhosis. This review describes the impact and significance of cholinergic anti-inflammatory pathway in the liver and discusses about its disease-related dysfunction on the progression of cirrhosis. Considering the fact that sepsis is major cause of death in cirrhotic patients, convergence of these findings, may lead to designing novel therapeutic strategies in the field of chronic liver diseases management involving selective drug targeting and electrical nerve stimulation.

Item Type: Article
Subjects: Library Keep > Medical Science
Depositing User: Unnamed user with email support@librarykeep.com
Date Deposited: 18 Apr 2023 07:56
Last Modified: 01 Jan 2024 12:58
URI: http://archive.jibiology.com/id/eprint/600

Actions (login required)

View Item
View Item